AAVrh.10 variants with host antibody escape capabilities and altered tissue targeting properties
Abstract:
This disclosure relates to variant AAVrh.10 particles engineered to escape host neutralizing antibodies but retain or improve transduction efficiency, and their use as gene delivery vehicles.
Information query
Patent Agency Ranking
0/0